ZEB2
protein-codingzinc finger E-box binding homeobox 2, the group of ZF class homeoboxes and pseudogenes|Zinc fingers C2H2-type
Gene summary
The protein encoded by this gene is a member of the Zfh1 family of 2-handed zinc finger/homeodomain proteins. It is located in the nucleus and functions as a DNA-binding transcriptional repressor that interacts with activated SMADs. Mutations in this gene are associated with Hirschsprung disease/Mowat-Wilson syndrome. Alternatively spliced transcript variants have been found for this gene.[provided by RefSeq, Jan 2010]
- ZFHX1B
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~156.7 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0009341
Submitter: ClinGen
*ZEB2* is located on chromosome 2q22.3 and encodes a transcription factor involved in multiple developmental processes. In the nervous system, ZEB2 regulates neuronal specification, migration, and differentiation. *ZEB2* was first reported in relation to autosomal dominant Mowat-Wilson syndrome in 2001 (Wakamatsu et al., PMID: 11279515; Cacheux et al., PMID: 11448942). Mowat-Wilson syndrome is characterized by moderate-to-severe intellectual disability, severe speech impairment, typical facial dysmorphic features, short stature with microcephaly, seizures, and congenital anomalies, including Hirschsprung disease, congenital heart defects, genitourinary abnormalities, and hypoplasia or agenesis of the corpus callosum. Eight variants (4 frameshift, 3 nonsense and 1 missense) that have been reported in eight probands in three publications (PMIDs: 11448942, 16053902, 38351292) are included in this curation. Variants are typically *de novo*. Most patients have truncating variants or gene deletions; pathogenic missense variants are rare and result in a milder clinical presentation. More evidence is available in the literature, but the maximum score for genetic evidence (12 points) has been reached. The mechanism of pathogenicity is loss of function. A specific DNA methylation signature can be observed in individuals with pathogenic variants in *ZEB2* (PMID: 38351292). This gene-disease relationship is also supported by mouse models and functional alteration in non-patient cells. In summary, there is definitive evidence supporting the relationship between *ZEB2* and autosomal dominant Mowat-Wilson syndrome. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This gene-disease pair was originally evaluated by the ClinGen Intellectual Disability and Autism Gene Curation Expert Panel on May 23, 2018. It was reevaluated on July 1, 2026 (SOP Version 12). As a result of this reevaluation, the classification did not change.
Inheritance Pattern: AD
Disease ID:MONDO:0009341
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0009341
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0009341
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0009341
Submitter: G2P
Clinical Genomic Database (CGD)
Manifestation: Craniofacial; Gastrointestinal; Genitourinary; Musculoskeletal; Neurologic; Ophthalmologic
Intervention: General
Rationale: The condition can include Hirschsprung disease, among other multi-systemic manifestations; Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to ZEB2 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_014795.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 8 | 339 | 3 | 350 | ||
| missense | 11 | 36 | 522 | 170 | 45 | 784 |
| nonsense | 99 | 17 | 3 | 119 | ||
| start loss | 3 | 3 | ||||
| frameshift | 201 | 42 | 5 | 248 | ||
| splice donor/acceptor (+/-2bp) | 12 | 8 | 2 | 22 | ||
| Total | 323 | 103 | 543 | 509 | 48 | 1526 |
Highest pathogenic variant AF is 0.0000020521632
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_055610.1 | 9 | MANE Select | |
| Ensembl | ENSP00000487174.1 | 9 | MANE Select | |
| RefSeq | NP_001165124.1 | 8 | Standard | |
| Ensembl | ENSP00000302501.4 | 9 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| zeb2b | Danio rerio | Structure: intrahepatic bile duct Quality: decreased length abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- MicroRNAs in cancer - Homo sapiens (human)
- TGF-beta Signaling Pathway
- EMT transition in Colorectal Cancer
- TGF-beta Receptor Signaling
- TGF_beta_Receptor
Biological Process
- negative regulation of transcription by RNA polymerase II
- neural crest cell migration
- somitogenesis
- neural tube closure
- nervous system development
Molecular Function
- DNA-binding transcription factor activity, RNA polymerase II-specific
- DNA-binding transcription repressor activity, RNA polymerase II-specific
- DNA-binding transcription activator activity, RNA polymerase II-specific
- protein binding
- phosphatase regulator activity
Cellular Component
- nuclear chromatin
- nucleus
- nucleolus
- cytosol
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000558170
- Coding exons
- 9
- Length
- 140500
- Individuals with no LoFs
- 124846
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 1
- Defined
- 124847
- p
- 0.00000400
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 3.94 | 378 | 664 | 0.569 | 0.0000377 | 8112 |
| Missense (PolyPhen) | 73 | 211.53 | 0.34511 | 2608 | ||
| Synonymous | -0.233 | 264 | 259 | 1.02 | 0.0000165 | 2239 |
| Loss of Function | 6.03 | 1 | 44.3 | 0.0226 | 0.00000251 | 583 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0 | 0.0 | absent |
| Ashkenazi Jewish | 0.000099 | 0.000099 | rare |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0 | 0.0 | absent |
| South Asian | 0 | 0.0 | absent |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Transcriptional inhibitor that binds to DNA sequence 5'- CACCT-3' in different promoters. Represses transcription of E- cadherin. {ECO:0000269|PubMed:16061479}.;
- Disease
- DISEASE: Mowat-Wilson syndrome (MOWS) [MIM:235730]: A complex developmental disorder characterized by mental retardation, delayed motor development, epilepsy, microcephaly and a wide spectrum of clinically heterogeneous features suggestive of neurocristopathies at the cephalic, cardiac, and vagal levels. Affected patients show an easily recognizable facial appearance with deep set eyes and hypertelorism, medially divergent, broad eyebrows, prominent columella, pointed chin and uplifted, notched ear lobes. Some patients manifest Hirschsprung disease. {ECO:0000269|PubMed:11448942, ECO:0000269|PubMed:12451214, ECO:0000269|PubMed:15384097, ECO:0000269|PubMed:16688751}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.223
Intolerance Scores
- LoFtool
- 0.0187
- RVIS EVS
- -0.91
- RVIS percentile EVS
- 10.03
Essentials
- Essential (CRISPR)
- E
- Essential (CRISPR2)
- S
- Essential (gene trap)
- K
- Indispensability pred.
- E
- Indispensability score
- 0.960
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |